Stan Yakatan: The paradigm shifter
22 April, 2002 by Tanya HollisStan Yakatan, "US venture capital raising guru" and strategic biotechnology adviser to the Victorian government, sits at a table in The Westin Melbourne's Allegro restaurant surrounded by breakfast, documents and five chairs intermittently filled and vacated biotech movers and shakers.
VC's biotech interest hits new heights
22 April, 2002 by Pete YoungVenture capitalists complain they are finding it ever-tougher to coax fresh funds from investors. Yet paradoxically, the total Australian pool of life science risk capital stands at record levels.
The language of biobusiness
22 April, 2002 by Daniella GoldbergSpend any time in the biobusiness sector and you learn one thing very quickly: it pays to be bilingual. And not in French or Spanish or Japanese, but in the languages of science and money.
Universities need IP strategy
19 April, 2002 by Melissa TrudingerMore attention needs to be paid to intellectual property, especially in Universities and institutions, is the message from Melbourne patent attorney Dr Neil Ireland.
Ambri scientist appointed to NSW Innovation Council
19 April, 2002 by Daniella GoldbergAmbri's Dr Bruce Cornell is the new addition to the NSW Innovation Council, after being appointed by the Treasurer and Minister for State Development, Michael Egan.
Singapore biomed is $64 million richer
18 April, 2002 by Iain ScottBiomedical research projects in Singapore have landed $S62.6 million (nearly $AU64 million) in the first round of a new grant scheme launched by the island nation's Agency for Science, technology and Research (A*Star).
Alchemia makes another deal
18 April, 2002 by Pete YoungDemand by drug discovery companies for carbohydrate chemistry specialist Alchemia's library of novel molecules is increasing. An agreement signed with US biotech CelTor BioSystems this week is the second collaborative pact Alchemia has announced in the past three weeks.
Workshop offers support for start-ups
18 April, 2002 by Daniella GoldbergEvisense, a Sydney University spin-off, holds the patents for some diagnostic devices that are potentially worth millions. The problem is that its inventor, Dr Richard Appleyard, is not able to work on developing his technologies.
GroPep MD dismissed
18 April, 2002 by Tanya HollisGroPep has sacked its managing director because of a difference of opinion over the company's direction.
QIMR learns tough lesson
17 April, 2002 by Pete YoungLeading Queensland medical research centre QIMR has discovered that swapping intellectual property for shares has its downside.
IBM, Mayo clinic team for medical database project
17 April, 2002 by Staff WritersIBM will provide the Mayo Clinic with database tools, permitting doctors at the famed hospital to compare notes with every other case the facility has on record, it announced today in a statement. Their goal is to make every doctor a research scientist.
Govt calls in expert biotech advice
17 April, 2002 by Daniella GoldbergA new council has been established to advise the Commonwealth government on priority issues in biotechnology, including R&D, international links, commercialisation, public interest and ethics.
Amrad: meeting to solve board dispute
17 April, 2002 by Tanya HollisAmrad Corporation has confirmed a general meeting will be held on May 22 to resolve a board dispute with its major shareholder, Fibre Optics.
Candida test breakthrough for Rockeby Biomed
17 April, 2002 by Melissa TrudingerClinical trials have validated the efficacy of a new test kit for diagnosis of systemic candidiasis, developed by Perth company Rockeby Biomed.
Peptech ditches CEO hunt
16 April, 2002 by Daniella GoldbergPeptech's worldwide hunt for a new CEO has been abandoned after three of the board members, including its Chairman Dr Ed Tweddell, walked out of the company last week under pressure from angry shareholders.
